^
Association details:
| Biomarker: | LPAR3 overexpression |
|---|---|
| Cancer: | Ovarian Cancer |
| Drug: | cisplatin (DNA synthesis inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer
Published date:
01/26/2022
Excerpt:
Our results showed that circ-LPAR3 was markedly upregulated in DDP-resistant OC tissues and cells.....To sum up, circ-LPAR3 might contribute to the DDP resistance of OC via the miR-634/PDK1 axis.
DOI:
10.1080/21655979.2022.2029109